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Abstract
Background: Cigars are a growing public health concern, given the changes in cigar use patterns in the US and
elsewhere since the 1960s. We conducted a systematic review of published studies on current cigar smoking and
all-cause and cause-specific mortality risks to inform potential regulatory approaches and future research that would
strengthen the body of evidence.
Methods: Using 3 different databases and handsearching, we identified epidemiological studies published prior to
June 2014 that examined the association between cigar smoking and all-cause mortality and smoking-related
mortality. Detailed study characteristics as well as association-level characteristics, including effect estimates and
95% confidence intervals, were abstracted or calculated from each selected study.
Results: A total of 22 studies from 16 different prospective cohorts were identified. Primary cigar smoking (current,
exclusive cigar smoking with no history of previous cigarette or pipe smoking) was associated with all
cause-mortality, oral cancer, esophageal cancer, pancreatic cancer, laryngeal cancer, lung cancer, coronary heart
disease (CHD), and aortic aneurysm. Strong dose trends by cigars per day and inhalation level for primary cigar
smoking were observed for oral, esophageal, laryngeal, and lung cancers. Among primary cigar smokers reporting
no inhalation, relative mortality risk was still highly elevated for oral, esophageal, and laryngeal cancers.
Conclusions: In summary, cigar smoking carries many of the same health risks as cigarette smoking. Mortality risks
from cigar smoking vary by level of exposure as measured by cigars per day and inhalation level and can be as
high as or exceed those of cigarette smoking. The body of evidence would be strengthened by future studies that
focus on the health effects of primary cigar smoking and incorporate more contemporary and diverse study
populations to better reflect the current patterns of cigar use in the US. Ideally, these studies would also collect
detailed information on cigar type, exposure level, and biomarkers of exposure and potential harm.
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Background
The 2009 Family Smoking Prevention and Tobacco Con-
trol Act (FSPTCA) provided the US Food and Drug
Administration (FDA) with regulatory authority over the
manufacture, distribution, and marketing of cigarettes, roll-
your-own tobacco, and smokeless tobacco. In April 2014,
the FDA issued a proposed rule to assert jurisdiction over
additional tobacco products, including cigars which are a
growing public health concern [1]. The US Centers for Dis-
ease Control and Prevention (CDC) has reported that from
2000 to 2011, cigar consumption more than doubled in the
US from slightly less than 6.2 billion sticks in 2000 to more
than 13.7 billion in 2011 [2]. Cigarette consumption, on the
other hand, declined by 33% in the US during this period.
In the US, the current cigar product landscape varies widely
with respect to flavors, pack sizes, brands and cigar types
(e.g., large cigars, cigarillos, and little filtered cigars) [3].
Cigar use among youth and young adults has been of par-
ticular concern in recent years. Nearly 16% of US young
adults ages 18 to 24 years reported having smoked cigars
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on at least one day in the past 30 days in 2009–2010 [4].
Nationally, 2.8% of middle school students and 12.6% of
high school students reported having smoked cigars (either
cigars, cigarillos or little cigars) on at least one day in the
past 30 days [5]. In the same study, cigar smoking preva-
lence significantly increased from 2011 to 2012 in non-
Hispanic Black high school students from 11.7% to 16.7%.
Cigar smoking produces numerous adverse health effects.
Cigar smoke contains many of the same toxic constituents
as cigarette smoke, and cigar smoke has been shown to
have higher levels of tobacco-specific nitrosamines
(TSNAs) than cigarette smoke due to the curing and fer-
mentation process for cigar tobacco [6]. Many of these
TSNAs such as N-Nitrosonornicotine (NNN) and nicotine-
derived nitrosamine ketone (NNK) are known carcinogens
[6]. Cigar smoke has also been found to have higher levels
of carbon monoxide and nitrogen oxide than cigarette
smoke [6]. The International Agency of Research on Can-
cer (IARC) has previously concluded in 2004 that cigar
and/or pipe smoking is causally connected to cancers of the
lung and upper aerodigestive tract, including the oral cavity,
oropharynx, hypopharynx, larynx and esophagus. They also
found evidence that cigar and/or pipe smoking are causally
associated with cancers of the pancreas, stomach and urin-
ary bladder [7,8]. A recent analysis of the population health
effects of cigar smoking found that regular cigar smoking is
responsible for at least 9,000 deaths each year in the US
and that the total number of deaths may be higher due to
potential increases in cigar smoking relative risks over time,
perhaps due to more diverse cigar products and changes in
inhalation patterns, as well as the possibility of deaths due
to other causes that have not been previously linked to
cigar smoking [9].
Given the public health and regulatory importance of
cigars, it is extremely timely and important to have ac-
curate and comprehensive information on the health ef-
fects of these products. This study presents a systematic
review of published studies on current cigar smoking
and all-cause and cause-specific mortality risks. In doing
so, it synthesizes the information currently available on
the subject and identifies areas for further research.
Methods
We conducted a systematic review of epidemiological
studies published prior to June 2014 that examined the
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Figure 1 Flowchart of study selection of prospective studies of cigar and all-cause and cause-specific mortality.
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Table 1 Selected prospective studies of cigar smoking and mortality
Author Publication
year




Age range Effect measure
reported
Kahn [28] 1966 US Dorn study 1954-1957 to 1962 248,195 N/A 31 to 84 SMR
Best [15] 1966 Canada Canadian Study of Smoking and Health 1956 to 1962 92,000 1,594 30 to 90 SMR
Cole [19] 1974 Denmark 1958 to 1972 183 N/A 55 to 64 Calculated IRR
Gordon [36] 1974 US Framingham 1948-1953 to 1966-1970 2,336 311 29 to 62 Calculated IRR
Doll [22] 1976 UK Male British Doctors 1951 to 1971 34,440 N/A 20 and older Calculated SMR
Jajich [27] 1984 US Cook County, IL 1965 to 1970 2,674 265 (18 females) 65 to 74 IRR
Carstensen [17] 1987 Sweden Swedish Census Cohort 1963 to 1979 25,129 N/A 18 to 69 SMR
Sandler [29] 1989 US Washington, County, MD 1963 to 1975 46,926 1,671 (10 females) 25 and older IRR, 95% CI
Hsing [25] 1990 US Dorn study 1954-1957 to 1980 249,829 N/A 31 to 84 IRR, 95% CI
Strachan [34] 1991 UK Nested case–control within Whitehall study cohort 1967-1969 to 1987 18,403 N/A 40 to 64 years OR, 95% CI
Lange [30] 1992 Denmark Copenhagen City Heart Study 1976 to 1989 14,214 808 (770 females) 20 and older HR, 95% CI
Chow [21] 1992 US Lutheran Brotherhood Insurance Society 1966 to 1986 17,818 N/A 35 years and older IRR, 95% CI
Chow [20] 1993 US Dorn study 1954-1957 to 1980 248,046 N/A 31 to 84 IRR, 95% CI
Ben-Shlomo [16] 1994 UK Whitehall study 1967-1969 to 1987 19,018 763 40 to 69 Calculated IRR
Heineman [24] 1995 US Dorn study 1954-1957 to 1980 248,046 N/A 31 to 84 IRR, 95% CI
Haheim [23] 1996 Finland Oslo study 1972 to 1992 16,173 1,623 40 to 49 HR, 95% CI
Wald [35] 1997 UK British United Provident Association 1975-1982 to 1993 21,520 1,831 35 to 64 HR, 95% CI
Shanks [31] 1998 US CPS-I 1959-1960 to 1972 442,455 15,191 (primary) 30 and older IRR, 95% CI
Jacobs [26] 1999 US CPS-II 1982 to 1991 121,278 6,914 30 years or older HR, 95% CI
Shapiro [33] 2000 US CPS-II 1982 to 1994 508,353 7,888 30 years or older HR, 95% CI
Chao [18] 2002 US CPS-II 1982 to 1996 467,788 6,945 30 years or older HR, 95% CI














cause-specific mortality. In doing so, we followed guide-
lines for systematic reviews from the Institute of Medi-
cine (IOM) [10], the Meta-analysis Of Observational
Studies in Epidemiology (MOOSE) group [11] and the
Cochrane Collaboration [12]. For cause-specific mortal-
ity, we selected causes and conditions identified as
smoking-related in the 2004 Surgeon General’s Report
on the health effects of smoking and IARC’s 2012 sum-
mary monograph “A Review of Human Carcinogens”
[13,14]. Based on these criteria, studies of cigar smoking
and the following causes of death were identified in the
research literature and included in this review: oral can-
cer, nasopharyngeal carcinoma, esophageal cancer, stom-
ach cancer, colon and rectal cancer, liver cancer,
pancreatic cancer, laryngeal cancer, lung cancer, bladder
cancer, kidney cancer, atherosclerosis, coronary heart
disease, stroke, aortic aneurysm, and chronic obstructive
pulmonary disease (COPD).
We conducted a search in PubMed using the following
terms: (cigar[tw] OR cigars[tw] OR cigarillo[tw] OR cigaril-
los[tw] OR cheroot[tw] OR cheroots[tw] OR stogies[tw])
AND (death[tw] OR mortality[tw]), yielding 100 potentially
Table 2 Current cigar smoking and all-cause mortality









of Smoking and Health
196 1.06 (0.92, 1.22) SMR Age
Kahn1966 Dorn study 1532 1.1 (1.05, 1.16) SMR Age
Cole1974 33 1.15 (0.70, 1.90) IRR
Carstensen1987 Swedish Census Cohort 131 1.39 (1.16, 1.65) SMR Age, residence
Lange1992 Copenhagen
City Heart Study
Men 326 1.6 (1.30, 2.00) HR Age
Lange1992 Copenhagen
City Heart Study
Women 185 1.8 (1.40, 2.20) HR Age
Ben-Shlomo1994 Whitehall study 9 0.48 (0.25, 0.93) IRR Primary Age
Ben-Shlomo1994 Whitehall study 132 1.2 (0.99, 1.46) IRR Secondary Age
Shanks1998 CPS-I 3754 1.08 (1.05, 1.12) IRR Primary Age
Shanks1998 CPS-I 1462 1.12 (1.06, 1.18) IRR Secondary Age
Current Cigar and/or Pipe
Cole1974 35 1.68 (1.03, 2.75) IRR
Gordon1974 Framingham 52 0.76 (0.51, 1.12) IRR
Doll1976 Male British Doctors 388 1.09 (0.98, 1.20) SMR Primary Age
Doll1976 Male British Doctors 595 1.13† (1.04, 1.22) SMR Secondary Age
Sandler1989 Washington, County, MD Men 504 1.2 (1.07, 1.35) IRR Age, marital status,
education, quality
of housing





113 1.23 (0.99, 1.75) HR Primary Age
Wald1997 British United
Provident Association
69 1.33 (1.03, 1.73) HR Secondary Age
Shaper2003 CPS-II 41 1.37 (0.99, 1.91) HR Primary Age, BMI, blood
pressure/hypertension,
serum cholesterol
Shaper2003 CPS-II 145 1.46 (1.18, 1.79) HR Secondary Age, BMI, blood
pressure/hypertension,
serum cholesterol
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; primary cigar and/or pipe smoking: current,
exclusive cigar and/or pipe smoking with no previous history of cigarette smoking; secondary cigar smoking: current, exclusive cigar smoking with previous
history of cigarette or pipe smoking; secondary cigar and/or pipe smoking: current, exclusive cigar and/or pipe smoking with previous history of
cigarette smoking.
†Based on corrected death rate of 1600 per 100,000 [43].
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pertinent references. We also conducted a search in
EMBASE using the following terms: (cigar OR cigars OR
cigarillo OR cigarillos OR cheroot OR cheroots OR stogies)
AND (‘death’/exp OR death OR ‘mortality’/exp OR mortal-
ity), yielding 207 potential references. Finally, we searched
ISI Web of Science using the terms: Topic = (cigar OR ci-
gars OR cigarillo OR cigarillos OR cheroot OR cheroots OR
stogies) AND Topic = (death OR mortality), yielding 92 po-
tential references. After removing duplicate records among
the three search results, there were a total of 246 references.
Study selection
At each stage of the study screening, two reviewers (CMC
and CGC) independently reviewed the studies and made
selections for inclusion (Figure 1). Final selections were
made after discussion and consensus was reached on dis-
crepant results. All selected studies were screened by title
and abstract, and the full texts of the subset of relevant pa-
pers were then reviewed. A total of 227 references were
excluded from review (see Additional file 1).
Because the focus of this review is on studies that exam-
ine current cigar smoking at baseline, we excluded an earl-
ier cohort study conducted by the American Cancer
Society that looked at mortality risks for lifetime ever cigar
smokers (w1-w2). A total of 108 references did not report
mortality risk associated with cigar use (w3-w110). An add-
itional 13 non-English studies were also excluded (w111-
w123). We excluded 90 non-epidemiologic or non-human
studies, including reviews and commentaries (w124-w213).
Two studies were excluded because they examined causes
of death (prostate cancer and multiple myeloma) that were
not classified as smoking-related in the 2004 Surgeon Gen-
eral’s Report or 2012 IARC monograph (w214-w215). Be-
cause the aim of this review was to compare mortality risks
relative to never tobacco users or never smokers, two stud-
ies with former or current cigarette smokers in their refer-
ence groups were excluded (w216-w217). We excluded 7
references because they only contained results from cohort
studies that were also published in studies that were se-
lected for review (w218-w224). Three references were
Table 3 Current cigar smoking and all-cause mortality by inhalation level and cigars per day
Study Cohort name Inhalation level Cigars per day Effect estimate 95% CI Measure Primary/secondary*
Kahn1966 Dorn study <5 1.04 (0.98, 1.11) SMR
Kahn1966 Dorn study 5 to 8 1.17 (1.06, 1.29) SMR
Kahn1966 Dorn study 8+ 1.49 (1.24, 1.77) SMR
Shanks1998 CPS-I 1 to 2 1.02 (0.97, 1.07) IRR Primary
Shanks1998 CPS-I 3 to 4 1.08 (1.02, 1.15) IRR Primary
Shanks1998 CPS-I 5+ 1.17 (1.10, 1.24) IRR Primary
Shanks1998 CPS-I 1 to 2 1.02 (0.93, 1.12) IRR Secondary
Shanks1998 CPS-I 3 to 4 1.17 (1.07, 1.28) IRR Secondary
Shanks1998 CPS-I 5+ 1.18 (1.08, 1.29) IRR Secondary
Shanks1998 CPS-I None 1.04 (1.00, 1.08) IRR Primary
Shanks1998 CPS-I Slight 1.19 (1.09, 1.30) IRR Primary
Shanks1998 CPS-I Moderate-deep 1.6 (1.38, 1.84) IRR Primary
Shanks1998 CPS-I None 1.04 (0.97, 1.11) IRR Secondary
Shanks1998 CPS-I Slight 1.16 (1.04, 1.29) IRR Secondary
Shanks1998 CPS-I Moderate-deep 1.33 (1.16, 1.51) IRR Secondary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
Table 4 Current cigar smoking and oral cancer








Kahn1966 Dorn study 9 4.11 (1.86, 7.84) SMR Age ICD 7: 140-150
Shanks1998 CPS-I 25 7.92 (5.12, 11.69) IRR Primary Age
Shanks1998 CPS-I 8 6.58 (2.83, 12.97) IRR Secondary Age




*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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excluded because they were unpublished meeting abstracts
(w225-w227). Finally, three additional references were iden-
tified by handsearching the references of relevant studies.
In total, 22 articles on cigar smoking and all-cause and
cause-specific mortality were included in this review
[15-36] (Figure 1 and Table 1).
Data extraction
Two different sets of data were extracted. The first dataset
consisted of study-level characteristics including cohort
name, country where study was conducted, publication
year of study, number of cigar users, age range of cohort
participants, year of enrollment, length of follow-up, out-
come type (i.e. all-cause or cause-specific mortality), and
relative mortality risk measure. The second dataset con-
sisted of association-level characteristics including relative
risk estimates as well as characteristics used to stratify esti-
mates such as age, type and level of cigar exposure, and
duration of cigar exposure. Thus, multiple entries could
occur for a particular study. Additionally, reported Inter-
national Classification of Diseases (ICD) codes from the
relevant revision were extracted for cause-specific mortal-
ity estimates. Although one included study, Shanks and
Burns (1998), did not report ICD codes in their analysis of
Cancer Prevention Study I (CPS-I) data, it can be assumed
that their cause of death coding system was similar to ICD
7, given that similar studies of CPS-I have used ICD 7
codes [37]. Data extraction was independently con-
ducted by two reviewers (CMC and CGC). Similar to
the selection of studies, data entries were compared
and any differences in data extraction were resolved
through discussion.
Table 5 Current cigar smoking and oral cancer by inhalation level, cigars per day, and duration
Study Cohort name Inhalation
level
Cigars per day Duration
(years)
Effect estimate 95% CI Measure Primary/
secondary*
Shanks1998 CPS-I 1 to 2 2.12 (0.43, 6.18) IRR Primary
Shanks1998 CPS-I 3 to 4 8.51 (3.66, 16.77) IRR Primary
Shanks1998 CPS-I 5+ 15.94 (8.71, 26.75) IRR Primary
Shanks1998 CPS-I 1 to 2 4.39 (0.06, 24.45) IRR Secondary
Shanks1998 CPS-I 5+ 13.73 (5.50, 28.30) IRR Secondary
Shapiro2000 CPS-II 1 to 2 0 (0.00, 0.00) HR Primary
Shapiro2000 CPS-II 3+ 7.6 (2.90, 19.60) HR Primary
Shanks1998 CPS-I None 6.98 (4.13, 11.03) IRR Primary
Shanks1998 CPS-I Slight 7.83 (1.57, 22.88) IRR Primary
Shanks1998 CPS-I Moderate-deep 27.88 (5.60, 81.46) IRR Primary
Shanks1998 CPS-I None 3.27 (0.66, 9.56) IRR Secondary
Shanks1998 CPS-I Slight 8.75 (1.76, 25.58) IRR Secondary
Shanks1998 CPS-I Moderate-deep 24.19 (2.72, 87.32) IRR Secondary
Shapiro2000 CPS-II No inhalation 3.2 (0.90, 11.00) HR Primary
Shapiro2000 CPS-II Inhalation 6.5 (1.40, 29.20) HR Primary
Shapiro2000 CPS-II <25 0 (0.00, 0.00) HR Primary
Shapiro2000 CPS-II 25+ 4.6 (1.60, 13.00) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
Table 6 Current cigar smoking and esophageal cancer








Kahn1966 Dorn study 12 5.33 (2.74, 9.34) SMR Age ICD 8: 150
Carstensen1987 Swedish Census Cohort 2 6.5 (0.61, 23.90) SMR Age, residence ICD 8: 150
Shanks1998 CPS-I 19 3.6 (2.17, 5.62) IRR Primary Age
Shanks1998 CPS-I 7 3.52 (1.41, 7.25) IRR Secondary Age
Shapiro2000 CPS-II 9 1.8 (0.90, 3.70) HR Primary Age, alcohol,
smokeless tobacco
ICD 9: 150
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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A number of studies did not report 95% confidence inter-
vals and/or relative mortality risks (see “Effect measure re-
ported” column in Table 1). For these studies, we calculated
these estimates using the available data. For standardized
mortality ratios (SMRs), we used the relevant formula from
Breslow et al. (equation 2.15) to calculate 95% confidence
intervals [38]. For incidence rate ratios (IRRs), we calcu-
lated 95% confidence intervals using Wald Limits [39].
The main exposure of interest was either current exclu-
sive cigar smoking or current exclusive cigar/pipe smok-
ing. Current cigarette smokers are excluded from this
analysis to better isolate the effects of cigar smoking on
disease risk. Past cigarette smoking patterns are likely to
affect current cigar smoking patterns. CPS-I results sug-
gest that secondary cigar smokers (current, exclusive cigar
smoking with a history of previous cigarette or pipe smok-
ing) are about twice as likely to report inhaling cigar
smoke as primary cigar smokers (current, exclusive cigar
smoking with no history of previous cigarette or pipe
smoking) (42.0% vs. 21.6%) [31]. Therefore, secondary
cigar smokers may have different disease risks compared
with primary cigar smokers not only due to past cigarette
use, but also due to differences in cigar use, particularly
with inhalation. Thus, for studies that assessed this infor-
mation, we present results for primary and secondary
cigar smokers separately as well as separate studies that
combine cigar and pipe use from studies of cigar use only.
Results
In total, there were 22 selected studies that examined
cigar smoking and mortality from 16 cohorts (Table 1).
All of the studies were from prospective cohorts for
which vital status was usually determined through either
active follow-up or linkage to a death registry (Strachan
conducted a case–control study nested within a pro-
spective cohort [34]). Four studies were published from
Table 7 Current cigar smoking and esophageal cancer by inhalation level, cigars per day, and duration




95% CI Measure Primary/
secondary*
Shanks1998 CPS-I 1 to 2 2.28 (0.74, 5.33) IRR Primary
Shanks1998 CPS-I 3 to 4 3.93 (1.43, 8.55) IRR Primary
Shanks1998 CPS-I 5+ 5.19 (2.23, 10.22) IRR Primary
Shanks1998 CPS-I 1 to 2 2.64 (0.03, 14.67) IRR Secondary
Shanks1998 CPS-I 3 to 4 1.56 (0.02, 8.68) IRR Secondary
Shanks1998 CPS-I 5+ 5.63 (1.81, 13.14) IRR Secondary
Shapiro2000 CPS-II 1 to 2 1.8 (0.60, 5.00) HR Primary
Shapiro2000 CPS-II 3+ 1.9 (0.80, 4.90) HR Primary
Shanks1998 CPS-I None 3.4 (1.90, 5.61) IRR Primary
Shanks1998 CPS-I Slight 1.9 (0.02, 10.58) IRR Primary
Shanks1998 CPS-I Moderate-deep 14.84 (2.98, 43.37) IRR Primary
Shanks1998 CPS-I None 4.15 (1.34, 9.68) IRR Secondary
Shanks1998 CPS-I Slight 2.22 (0.03, 12.37) IRR Secondary
Shanks1998 CPS-I Moderate-deep 2.69 (0.04, 14.94) IRR Secondary
Shapiro2000 CPS-II No inhalation 1.6 (0.70, 4.10) HR Primary
Shapiro2000 CPS-II Inhalation 1 (0.10, 7.20) HR Primary
Shapiro2000 CPS-II <25 0.9 (0.10, 6.40) HR Primary
Shapiro2000 CPS-II 25+ 2.2 (1.00, 4.70) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.







95% CI Measure Adjustment ICD codes
Current Cigar
Kahn1966 Dorn Study 23 1.2 (0.76, 1.80) SMR Age ICD 7: 151
Chao2002 CPS-II 25 2.29 (1.49, 3.51) HR Age, education, race, family history of stomach
cancer,high-fiber grain foods, vegetables, citrus
fruits/juices,
ICD 9: 151.0-151.9
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the Dorn study cohort which approximately 250,000
government life-insurance policy holders (mostly US
World War I veterans) responded to questionnaires on
tobacco use mailed to them in the 1950s. Two studies
were published from the Whitehall study cohort in
which over 18,000 men aged 40–69 years from the
British Civil Service underwent an examination between
1967 and 1969 which included reporting health history
and lifetime smoking habits. Finally, three studies were
published from the American Cancer Society’s Cancer
Prevention Study II (CPS-II) cohort in which over a half
million male volunteers from all 50 US states completed
a self-administered questionnaire in 1982. Women were
not included in CPS-II studies of cigar use because they
were not asked if they smoked cigars. One of the 16 co-
horts began in the 1940s, five cohorts began in the
1950s, five cohorts began in the 1960s, four cohorts
began in the 1970s, and one cohort began in the 1980s.
The studies were conducted primarily in North America
and Europe with 12 in the US, five in the United Kingdom
(UK), one in Canada, and four in Nordic countries
(Denmark, Sweden, and Finland).
We found a substantial amount of variation across
studies in terms of study characteristics including the
definition of tobacco exposure (e.g. assessment of past
cigarette smoking, inclusion of current pipe smoking),
dose categories, and adjustment for possible confound-
ing risk factors. Furthermore, CPS-I and II were the only
cohorts large enough to yield results for primary cigar
smokers and secondary cigar smokers separately for
most outcomes. Thus, we present the results descrip-
tively, rather than giving pooled relative risk estimates.
In the subsequent results, we refer to effect estimates as
“mortality ratios” or MRs, regardless of whether they are
age-standardized mortality ratios, hazards ratios (HR),
incidence rate ratios (IRR) or odds ratios (OR). We
present MRs for current cigar smoking only (rather than
ever or former cigar smoking). The referent group is
never smokers or never tobacco users. Results for all-
cause mortality and cause-specific mortality are pre-
sented. Estimates for groups of causes, such as cancers
of the digestive system or genitourinary system, were
not included in our results. For each outcome, we
present results in the following order of exposure: pri-
mary cigar smoking (current, exclusive cigar smoking
with no previous history of cigarette or pipe smoking),
primary cigar and/or pipe smoking (current, exclusive
cigar and/or pipe smoking with no previous history of
cigarette smoking), secondary cigar smoking (current,
exclusive cigar smoking with previous history of
cigarette or pipe smoking), secondary cigar and/or pipe
smoking (current, exclusive cigar and/or pipe smoking
with previous history of cigarette smoking), any current
cigar smoking (regardless of cigarette/pipe smoking his-
tory), and any current cigar/pipe smoking (regardless of
cigarette smoking history). Following overall cigar expos-
ure, we then present results (when available) by level of
cigar exposure (cigars per day), inhalation (any or the re-
ported level), and duration of cigar smoking.
All-cause mortality
All-cause mortality results are presented in Tables 2 and
3. Two studies reported all-cause mortality risk among
primary cigar smokers. Shanks and Burns found a
Table 9 Current cigar smoking and stomach cancer by inhalation level, cigars per day, duration, and age started
smoking cigars




Duration (years) Age started
cigars (years)
Effect estimate 95% CI P-trend Measure
Chao2002 CPS-II 1 to 4 1.68 (0.95, 2.97) HR
Chao2002 CPS-II 5+ 4.2 (2.32, 7.60) 0.746 HR
Chao2002 CPS-II None 2.08 (1.22, 3.57) HR
Chao2002 CPS-II Slight to deep 3.93 (1.92, 8.04) HR
Chao2002 CPS-II ≤39 2.42 (1.36, 4.28) HR
Chao2002 CPS-II ≥40 2.55 (1.32, 4.94) 0.079 HR
Chao2002 CPS-II ≤19 2.78 1.23 6.28 HR
Chao2002 CPS-II 20-29 3.01 1.65 5.49 HR
Chao2002 CPS-II ≥30 1.74 0.71 4.24 0.617 HR
Table 10 Current cigar smoking and liver cancer
Study Cohort name Cigar smoker deaths Effect estimate 95% CI Measure Adjustment ICD codes
Carstensen1987 Swedish Census Cohort 4 7.2 (1.87, 18.62) SMR Age, residence ICD 8: 155-156
Hsing1990 Dorn study 47 3.1 (2.00, 4.80) IRR Age, calendar time ICD 7: 155.0
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significant positive association (MR = 1.08, 95% CI =
1.05-1.12) based on 3,754 cigar smoker deaths in CPS-I,
whereas Ben-Shlomo reported an inverse association be-
tween cigar smoking and all-cause mortality based on a
much smaller cohort with only 9 cigar smoker deaths
(Table 2). In three cigar studies that also included pipe
smoking, primary pipe/cigar smoking was associated
with slight increases in all-cause mortality risks (MRs
1.09 to 1.37), and all of these associations just missed
conventional thresholds for statistical significance with
the lower bounds of the 95% confidence intervals being
at least 0.98. All-cause mortality risks were increased in
two studies reporting risks for secondary cigar smoking
(MRs 1.12 to 1.20), and one association was statistically
significant while the other just missed statistical signifi-
cance with 0.99 as the lower bound of the 95% confi-
dence interval. All three studies on secondary cigar/pipe
smoking found significant increases in all-cause mortal-
ity (MRs 1.13 to 1.46). Overall, MRs for all-cause mor-
tality among current cigar smokers ranged from 0.48 to
1.60 and 0.70 to 1.68 among current cigar/pipe smokers.
Among primary cigar smokers in CPS-1, smoking 3 or
more cigars per day (MRs 1.08-1.17) and higher levels of
cigar smoke inhalation (MRs 1.19-1.60) were both asso-
ciated with significantly increased risk of all-cause mor-
tality (Table 3).
Table 11 Current cigar smoking and pancreatic cancer








Kahn1966 Dorn study 27 1.52 (1.00, 2.21) SMR Age ICD 7: 157
Carstensen1987 Swedish Census Cohort 1 1 (0.00, 5.73) SMR Age, residence ICD 8: 140–146,
148, 161
Shanks1998 CPS-I 56 1.62 (1.22, 2.11) IRR Primary Age
Shanks1998 CPS-I 20 1.8 (1.10, 2.78) IRR Secondary Age
Shapiro2000 CPS-II 28 1.3 (0.90, 1.90) HR Primary Age, alcohol,
smokeless tobacco
ICD 9: 157
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.











95% CI Measure Primary/
secondary*
Shanks1998 CPS-I 1 to 2 1.18 (0.69, 1.89) IRR Primary
Shanks1998 CPS-I 3 to 4 1.51 (0.86, 2.45) IRR Primary
Shanks1998 CPS-I 5+ 2.21 (1.40, 3.32) IRR Primary
Shanks1998 CPS-I 1 to 2 0.56 (0.06, 2.01) IRR Secondary
Shanks1998 CPS-I 3 to 4 1.9 (0.82, 3.74) IRR Secondary
Shanks1998 CPS-I 5+ 3.71 (1.78, 6.83) IRR Secondary
Shapiro2000 CPS-II 1 to 2 0.6 (0.30, 1.40) HR Primary
Shapiro2000 CPS-II 3+ 1.6 (1.00, 2.50) HR Primary
Shanks1998 CPS-I None 1.55 (1.12, 2.07) IRR Primary
Shanks1998 CPS-I Slight 2.16 (0.99, 4.10) IRR Primary
Shanks1998 CPS-I Moderate-deep 2.26 (0.45, 6.60) IRR Primary
Shanks1998 CPS-I None 1.55 (0.80, 2.72) IRR Secondary
Shanks1998 CPS-I Slight 1.92 (0.52, 4.92) IRR Secondary
Shanks1998 CPS-I Moderate-deep 2.53 (0.51, 7.39) IRR Secondary
Shapiro2000 CPS-II No inhalation 0.9 (0.50, 1.50) HR Primary
Shapiro2000 CPS-II Inhalation 2.7 (1.50, 4.80) HR Primary
Shapiro2000 CPS-II <25 1.5 (0.70, 3.30) HR Primary
Shapiro2000 CPS-II 25+ 1.1 (0.70, 1.80) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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Oral cancer
Results for mortality from oral cancer are presented in
Tables 4 and 5. Shanks and Burns and Shapiro, Jacobs,
and Thun both found significantlyelevated risk of oral
cancer mortality for primary cigar smokers in CPS-I and
II (Table 4). Secondary cigar smoking was also signifi-
cantly associated with death from oral cancer in CPS-I.
Overall, current cigar smoking MRs ranged from 4 to
7.9. Strong dose–response trends were observed for
cigars per day, level of inhalation, and duration in both
studies of primary cigar smoking in CPS-I and II
(Table 5). Primary cigar smokers reporting no inhalation
also had significantly elevated risk of oral cancer mortal-
ity in CPS-I (MR = 6.98, 95% CI = 4.13-11.03). Risk of
oral cancer was elevated but not statistically significant
(MR = 2.12, 95% CI = 0.43-6.18) among primary cigar
smokers who smoked 1–2 cigars per day in CPS-I, pre-
sumably due to small sample size, based on the wide
confidence interval. Risk could not be estimated in CPS-
II due to 0 exposed cases smoking 1–2 cigars per day.
Esophageal cancer
Results for deaths from esophageal cancer are presented
in Tables 6 and 7. Shanks and Burns observed a signifi-
cant positive association between primary cigar smoking
and esophageal cancer mortality in CPS-I (MR = 3.60,
95% CI = 2.17-5.62) based on 19 exposed cases (Table 6).
Shapiro, Jacobs, and Thun observed an elevated, but
non-significant association in CPS-II (MR = 1.80, 95%
CI = 0.90-3.70) based on 9 exposed cases, and was thus
underpowered to detect this association. Shanks and
Burns also observed a significant association for second-
ary cigar smoking in CPS-I. Current cigar smoking MRs
ranged from 1.8 to 6.5. In CPS-I, Shanks and Burns
found strong dose–response trends for cigars per day
and depth of inhalation among primary cigar smokers
(Table 7), even though an elevated risk was still observed
among those reporting no inhalation (MR = 3.40, 95%
CI = 1.90, 5.61). Risk of esophageal cancer was elevated
but not statistically significant among primary cigar
smokers who smoked 1–2 cigars per day in both CPS-I
(MR = 2.28, 95% CI = 0.74-5.33) and CPS-II (MR = 1.80,
95% CI = 0.60-5.00, based on 4 exposed cases). Based on
the wide confidence intervals, both cohorts appear to be
underpowered to detect an association at this level of
exposure due to small sample size.
Stomach cancer
Mortality risk estimates for stomach cancer are pre-
sented in Tables 8 and 9. Overall, current cigar smoking
MRs were 1.2 in the Dorn study cohort and 2.29 from
CPS-II, with the estimate from CPS-II being statistically
Table 13 Current cigar smoking and laryngeal cancer
Study Cohort name Cigar smoker
deaths




Kahn1966 Dorn study 6 10.33 (3.72, 22.63) SMR Age ICD 7: 161
Shanks1998 CPS-I 7 10.02 (4.01, 20.64) IRR Primary Age
Shapiro2000 CPS-II 4 10.3 (2.60, 41.00) HR Primary Age, alcohol,
smokeless tobacco
ICD 9: 161
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
Table 14 Current cigar smoking and laryngeal cancer by inhalation level, cigars per day, and duration
Study Cohort name Inhalation level Cigars per day Duration
(years)
Effect estimate 95% CI Measure Primary/
secondary*
Shanks1998 CPS-I 1 to 2 6.45 (0.72, 23.27) IRR Primary
Shanks1998 CPS-I 5+ 26.03 (8.39, 60.74) IRR Primary
Shapiro2000 CPS-II 1 to 2 6 (0.70, 53.50) HR Primary
Shapiro2000 CPS-II 3+ 15 (3.40, 65.90) HR Primary
Shanks1998 CPS-I None 10.6 (3.87, 23.07) IRR Primary
Shanks1998 CPS-I Moderate-deep 53.26 (0.70, 296.32) IRR Primary
Shapiro2000 CPS-II No inhalation 4.2 (0.50, 37.10) HR Primary
Shapiro2000 CPS-II Inhalation 39 (8.40, 180.10) HR Primary
Shapiro2000 CPS-II <25 0 (0.00, 0.00) HR Primary
Shapiro2000 CPS-II 25+ 13.7 (3.40, 54.50) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
Chang et al. BMC Public Health    Page 10 of 20
significant (Table 8). Stronger associations were ob-
served for the highest levels of both cigars per day and
inhalation in CPS-II (Table 9). Cigar smoking was found
to be associated with stomach cancer mortality in CPS-
II for both less than 40 years of cigar smoking and
40 years or more of cigar smoking.
Liver cancer
Results for liver cancer are presented in Table 10. Studies
of liver cancer mortality risk for cigar smoking are limited.
Both studies of current cigar smoking showed significant
associations with deaths from liver cancer; however, nei-
ther study reported cigarette smoking history.
Pancreatic cancer
Results for deaths from pancreatic cancer are presented in
Tables 11 and 12. Shanks and Burns found a significant as-
sociation between primary cigar smoking and pancreatic
cancer mortality in CPS-I, while Shapiro, Jacobs, and
Thun did not find a significant association in CPS-II
(Table 11). Shanks and Burns also found a significant asso-
ciation with pancreatic cancer mortality risk for secondary
cigar smokers. Overall, current cigar smoking MRs ranged
from 1 to 1.8. A weak dose–response trend was seen for
cigars per day in CPS-I and II (Table 12). Inhalation was
associated with pancreatic cancer mortality in CPS-II, and
some evidence of a dose–response trend for inhalation
was observed in CPS-I.
Laryngeal cancer
The results for deaths from laryngeal cancer are presented
in Tables 13 and 14. Shanks and Burns and Shapiro,
Jacobs, and Thun found significant positive associations
between primary cigar smoking and laryngeal cancer mor-
tality risk in CPS-I and CPS-II that were of similar magni-
tude (MRs = 10) (Table 13). Kahn also found a significant
association of the same magnitude among current cigar
smokers. Shanks and Burns and Shapiro, Jacobs, and Thun
observed a strong dose–response relationship for cigars
per day and level of inhalation, and Shapiro, Jacobs, and
Thun observed similar trends for duration of cigar smok-
ing (Table 14). Shanks and Burns also observed that pri-
mary cigar smokers reporting no inhalation in CPS-I had
significantly elevated risk of mortality from laryngeal can-
cer (MR = 10.6, 95% CI = 3.87-23.07). Risk of laryngeal
cancer was highly elevated but not statistically significant
among primary cigar smokers who smoked 1–2 cigars per
day in both CPS-I (MR = 6.45, 95% CI = 0.72-23.27) and
CPS-II (MR = 6.00, 95% CI-0.70-53.50, based on 1 exposed
case). Based on the wide confidence intervals, both
Table 15 Current cigar smoking and lung cancer










Kahn1966 Dorn study 25 1.59 (1.03, 2.35) SMR Age ICD 7: 162-163
Carstensen1987 Swedish Census
Cohort
11 7.6 (3.77, 13.65) SMR Age, residence ICD 8: 162
Lange1992 Copenhagen City
Heart Study
Men 47 6 (2.20, 17.00) HR Age ICD 8: 162
Lange1992 Copenhagen City
Heart Study
Women 14 4.9 (3.00,12.00) HR Age ICD 8: 162
Ben-Shlomo1994 Whitehall study 1 1.8 (0.24, 13.31) IRR Primary Age ICD 8: 162
Ben-Shlomo1994 Whitehall study 20 7.64 (4.22, 13.83) IRR Secondary Age ICD 8: 162
Shanks1998 CPS-I 73 2.1 (1.63, 2.65) IRR Primary Age
Shanks1998 CPS-I 83 6.29 (5.01, 7.79) IRR Secondary Age




Current Cigar and/or Pipe
Chow1992 Dorn study 4 3.5 (1.00, 12.60) HR Age, occupation
Wald1997 British United
Provident Association
6 3.19 (1.07, 9.50) HR Primary Age ICD 9: 162
Wald1997 British United
Provident Association
9 8.64 (3.19, 23.30) HR Secondary Age ICD 9: 162
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; primary cigar and/or pipe smoking: current,
exclusive cigar and/or pipe smoking with no previous history of cigarette smoking; secondary cigar smoking: current, exclusive cigar smoking with previous
history of cigarette or pipe smoking; secondary cigar and/or pipe smoking: current, exclusive cigar and/or pipe smoking with previous history of
cigarette smoking.
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cohorts appear to be underpowered to detect an associ-
ation at this level of exposure due to small sample size.
Lung cancer
Lung cancer mortality risk estimates are presented in
Tables 15 and 16. Shanks and Burns and Shapiro, Jacobs,
and Thun found significant positive associations with
lung cancer mortality risk in CPS-I and II, although
Ben-Shlomo did not observe a significant association in
a much smaller cohort (Table 15). Wald found a
significant association between primary cigar/pipe smok-
ing and lung cancer mortality risk. Shanks and Burns
and Ben-Shlomo found a significant positive association
between lung cancer mortality and secondary cigar
smoking as did Wald for secondary cigar/pipe smoking.
Overall, current cigar smoking MRs ranged from 1.59 to
7.64, and current cigar/pipe smoking MRs ranged from
3.19 to 8.64. Dose–response trends were observed for ci-
gars per day, level of inhalation, and duration in CPS-I
and II data (Table 16).
Table 16 Current cigar smoking and lung cancer by inhalation level, cigars per day, and duration






Effect estimate 95% CI Measure Primary/
secondary*
Kahn1966 Dorn study <5 1.14 (0.59, 2.00) SMR
Kahn1966 Dorn study 5 to 8 2.64 (1.31, 4.74) SMR
Kahn1966 Dorn study 8+ 2.07 (0.20, 7.61) SMR
Shanks1998 CPS-I 1 to 2 0.9 (0.54, 1.66) IRR Primary
Shanks1998 CPS-I 3 to 4 2.36 (1.49, 3.54) IRR Primary
Shanks1998 CPS-I 5+ 3.4 (2.34, 4.77) IRR Primary
Shanks1998 CPS-I 1 to 2 3.18 (1.78, 5.24) IRR Secondary
Shanks1998 CPS-I 3 to 4 8.52 (5.87, 11.97) IRR Secondary
Shanks1998 CPS-I 5+ 7.21 (5.02, 10.03) IRR Secondary
Shapiro2000 CPS-II 1 to 2 1.3 (0.70, 2.40) HR Primary
Shapiro2000 CPS-II 3+ 7.8 (5.90, 10.30) HR Primary
Shanks1998 CPS-I None 1.97 (1.48, 2.57) IRR Primary
Shanks1998 CPS-I Slight 1.89 (0.81, 3.72) IRR Primary
Shanks1998 CPS-I Moderate-deep 4.93 (1.80, 10.72) IRR Primary
Shanks1998 CPS-I None 5.41 (3.93, 7.27) IRR Secondary
Shanks1998 CPS-I Slight 7.63 (4.66, 11.78) IRR Secondary
Shanks1998 CPS-I Moderate-deep 9.77 (5.88, 15.25) IRR Secondary
Shapiro2000 CPS-II No inhalation 3.3 (2.30, 4.70) HR Primary
Shapiro2000 CPS-II Inhalation 11.3 (7.90, 16.10) HR Primary
Shapiro2000 CPS-II <25 2.1 (1.00, 4.20) HR Primary
Shapiro2000 CPS-II 25+ 5.9 (4.50, 7.70) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
Table 17 Current cigar smoking and bladder cancer








Kahn1966 Dorn study 10 0.94 (0.45, 1.74) SMR Age ICD 7: 181
Carstensen1987 Swedish Census Cohort 1 1.9 (0.00, 10.89) SMR Age, residence ICD 8: 188
Shanks1998 CPS-I 25 1.38 (0.89, 2.04) IRR Primary Age
Shanks1998 CPS-I 9 1.23 (0.56, 2.33) IRR Secondary Age
Shapiro2000 CPS-II 6 1 (0.40, 2.30) HR Primary Age, alcohol,
smokeless tobacco
ICD 9: 188
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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Bladder cancer
The results for deaths from bladder cancer are presented
in Tables 17 and 18. Neither Shanks and Burns nor
Shapiro, Jacob, and Thun found an association between
primary cigar smoking and bladder cancer mortality risk
in CPS-I and CPS-II, respectively, and Shanks and Burns
did not find an association with secondary cigar smoking
(Table 17). Overall, current cigar smoking MRs ranged
from 0.94 to 1.9. There was no dose–response trend for
cigars per day among primary and secondary cigar
smokers in both CPS-I and CPS-II. Shanks and Burns
did not find increased mortality risk with depth of inhal-
ation in CPS-I, but Shapiro, Jacobs, and Thun did find a
significant association with inhalation among primary
cigar smokers (Table 18).
Coronary heart disease
Mortality results due to coronary heart disease (CHD)
are presented in Tables 19 and 20. Primary cigar smok-
ing was significantly associated with CHD mortality in
CPS-I (MR = 1.05, 95% CI = 1.00-1.11). Primary cigar
smoking was also associated with CHD mortality in
CPS-II men aged 30–74 years (MR = 1.30, 95% CI =
1.05-1.62), but not in men 75 years and older. Primary
cigar smoking was also not associated with CHD mortal-
ity in the much smaller Whitehall study cohort. The one
study on primary cigar/pipe smoking from Wald did not
observe an increased risk of death from CHD. CPS-I
also found increased CHD mortality risk to be associated
with secondary cigar smoking (MR = 1.09, 95% CI =
1.01-1.18), although the small Whitehall study cohort
did not. Wald did not find an association between sec-
ondary cigar/pipe smoking and CHD mortality risk.
Overall, the current cigar smoking MRs ranged from
0.45 to 1.30, and the current cigar/pipe MRs ranged
from 0.98 to 1.67. There was a weak dose–response rela-
tionship with cigars per day and level of inhalation
among primary but not secondary cigar smokers in the
CPS-I study (Table 20). Primary cigar smoking for
25 years or more was also associated with increased
CHD mortality risk in CPS-II men aged 30–74 years.
Stroke
Results for stroke are presented in Tables 21 and 22.
Shanks and Burns did not find a significant association
with stroke mortality risk for either primary or second-
ary cigar smoking in CPS-I (Table 21). Overall, current
cigar smoking MRs ranged from 0.92 to 1.08, and
Haheim found a significantly increased risk of death
from stroke for cigar/pipe smoking (MR = 3.6, 95% CI =
1.05-12.3). However, there was no dose–response trend
for cigars per day and level of inhalation among primary
and secondary cigar smokers in CPS-I (Table 22).
Aortic aneurysm
Mortality risk estimates for aortic aneurysm are pre-
sented in Tables 23 and 24. Shanks and Burns found
significant positive associations for aortic aneurysm
Table 18 Current cigar smoking and bladder cancer by inhalation level, cigars per day, and duration




Effect estimate 95% CI Measure Primary/
secondary*
Shanks1998 CPS-I 1 to 2 0.78 (0.29, 1.71) IRR Primary
Shanks1998 CPS-I 3 to 4 1.68 (0.77, 3.18) IRR Primary
Shanks1998 CPS-I 5+ 2.03 (0.97, 3.73) IRR Primary
Shanks1998 CPS-I 1 to 2 1.02 (0.20, 2.97) IRR Secondary
Shanks1998 CPS-I 3 to 4 2.36 (0.76, 5.50) IRR Secondary
Shanks1998 CPS-I 5+ 0.32 (0.00, 1.80) IRR Secondary
Shapiro2000 CPS-II 1 to 2 0 (0.00, 0.00) HR Primary
Shapiro2000 CPS-II 3+ 1.9 (0.80, 4.40) HR Primary
Shanks1998 CPS-I None 1.57 (1.00, 2.36) IRR Primary
Shanks1998 CPS-I Moderate-deep 1.52 (0.02, 8.44) IRR Primary
Shanks1998 CPS-I None 0.77 (0.21, 1.98) IRR Secondary
Shanks1998 CPS-I Slight 2.87 (0.58, 8.40) IRR Secondary
Shanks1998 CPS-I Moderate-deep 1.45 (0.16, 5.25) IRR Secondary
Shapiro2000 CPS-II No inhalation 0.5 (0.10, 2.10) HR Primary
Shapiro2000 CPS-II Inhalation 3.6 (1.30, 9.90) HR Primary
Shapiro2000 CPS-II <25 0 (0.00, 0.00) HR Primary
Shapiro2000 CPS-II 25+ 1.1 (0.40, 2.70) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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mortality for both primary and secondary cigar smok-
ing in CPS-I (Table 23). Overall, current cigar smoking
MRs ranged from 1.76 to 5.10, while Strachan found
that current cigar/pipe smoking was associated with a
five-fold increased risk of death from aortic aneurysm
(MR = 5.40, 95% CI = 1.90-15.30). There were no clear
dose–response trends for cigars per day and levels of in-
halation with in CPS-I (Table 24). Notably, risk of aor-
tic aneurysm was significantly elevated among primary
cigar smokers who smoked 1–2 cigars per day in CPS-I
(MR = 1.82, 95% CI = 1.11-2.81).
COPD
Results for deaths from chronic obstructive pulmonary
disease (COPD) are presented in Tables 25 and 26.
Shanks and Burns found that COPD mortality was not
associated with primary cigar smoking but was signifi-
cantly associated with secondary cigar smoking (MR =
4.39, 95% CI = 3.02-6.16) in CPS-I (Table 25). Wald
found that COPD mortality was not associated with pri-
mary cigar/pipe smoking but was significantly associated
with secondary cigar/pipe smoking. Overall, current
cigar smoking MRs ranged from 0.79 to 4.39, while
current cigar/pipe smoking MRs ranged from 1.11 to
1.68. For cigars per day, there were no dose–response
trends for primary cigar smoking, but there were strong
dose–response trends for secondary cigar smoking in
CPS-I (Table 26). For level of inhalation, there were sug-
gestive dose–response trends for primary and secondary
cigar smoking.
Other causes of death
For a number of causes of death (atherosclerosis, cancers
of the kidney, nasopharynx, colon and rectum), there
were only single estimates of associations with cigar
smoking (Table 27). All estimates come from the Dorn
study cohort. Although estimates for colon and rectal
cancer were also reported by Kahn, Heineman reported
more up-to-date associations for these cancer sites. Only
colon and rectal cancer were significantly associated
with primary current cigar/pipe smoking after adjusting
for age, calendar time, year of questionnaire response,
SES, sedentary job. For colon cancer only, there was a
significant dose-trend for the number of cigars smoked a
day after adjusting for the same factors (p-trend = 0.004,
data not shown).
Table 19 Current cigar smoking and coronary heart disease









Kahn1966 Dorn study 623 1.04 (0.96, 1.13) SMR Age ICD 7: 420
Carstensen1987 Swedish Census Cohort 42 1.16 (0.84, 1.57) SMR Age, residence ICD 8: 410-414
Ben-Shlomo1994 Whitehall study 4 0.45 (0.17, 1.22) IRR Primary Age ICD 8: 410-414
Ben-Shlomo1994 Whitehall study 42 0.91 (0.65, 1.27) IRR Secondary Age ICD 8: 410-414
Shanks1998 CPS-I 1505 1.05 (1.00, 1.11) IRR Primary Age
Shanks1998 CPS-I 609 1.09 (1.01, 1.18) IRR Secondary Age




tob smoke, vit C supplements
ICD 9: 410-414




tob smoke, vit C supplements
ICD 9: 410-414
Current Cigar and/or Pipe
Jajich1984 Cook County, IL 32 1.67 (1.11, 2.50) IRR
Wald1997 British United
Provident Association
33 0.98 (0.67, 1.44) HR Primary Age ICD 9: 410-414
Wald1997 British United
Provident Association
25 1.29 (0.88, 1.99) HR Secondary Age ICD 9: 410-414
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; primary cigar and/or pipe smoking: current,
exclusive cigar and/or pipe smoking with no previous history of cigarette smoking; secondary cigar smoking: current, exclusive cigar smoking with previous
history of cigarette or pipe smoking; secondary cigar and/or pipe smoking: current, exclusive cigar and/or pipe smoking with previous history of
cigarette smoking.
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Discussion
We have conducted a systematic review of the mortality
risks associated with cigar smoking that identified 22
studies from 16 cohorts that assessed the relative mor-
tality risks of cigar smokers compared with never to-
bacco users or never smokers. There was substantial
variation across studies in terms of study characteristics
including exposure definitions, types of effect measures,
and adjustments for confounding. We prioritized esti-
mates of primary cigar smoking (vs. never tobacco users
or never smokers) with the aim of isolating the health ef-
fects of cigar smoking apart from other current or past
tobacco smoking. We also placed emphasis on the larger
cohorts, primarily the American Cancer Society’s Cancer
Prevention Study I (CPS-I) and to a lesser extent CPS-II,
which was conducted more recently than CPS-I but had
half the number of primary cigar smokers as CPS-I
(7,888 and 15,191 primary cigar smokers, respectively).
The following mortality outcomes were significantly as-
sociated with primary cigar smoking overall in one or
both CPS cohorts: all cause-mortality; oral cancer,
esophageal cancer, pancreatic cancer, laryngeal cancer,
lung cancer, coronary heart disease (CHD), and aortic
aneurysm. Dose trends (cigars per day) for primary cigar
smoking were observed for oral, esophageal, laryngeal,
and lung cancers. Increased risks for oral, esophageal, la-
ryngeal, and lung cancers were observed with increasing
or any inhalation. It is notable that relative mortality risk
Table 20 Current cigar smoking and coronary heart disease by inhalation level, cigars per day and duration






95% CI Measure Primary/
secondary*
Kahn1966 Dorn study <5 1 (0.90, 1.10) SMR
Kahn1966 Dorn study 5 to 8 1.1 (0.94, 1.28) SMR
Kahn1966 Dorn study 8+ 1.18 (0.86, 1.59) SMR
Shanks1998 CPS-I 1 to 2 0.98 (0.91, 1.07) IRR Primary
Shanks1998 CPS-I 3 to 4 1.06 (0.96, 1.16) IRR Primary
Shanks1998 CPS-I 5+ 1.14 (1.03, 1.24) IRR Primary
Shanks1998 CPS-I 1 to 2 1.06 (0.92, 1.21) IRR Secondary
Shanks1998 CPS-I 3 to 4 1.1 (0.95, 1.27) IRR Secondary
Shanks1998 CPS-I 5+ 1.1 (0.96, 1.26) IRR Secondary
Jacobs1999 CPS-II (age 30–74 years) 1 1.18 (0.76, 1.82) HR Primary
Jacobs1999 CPS-II (age 30–74 years) 2 to 3 1.43 (1.03, 1.99) HR Primary
Jacobs1999 CPS-II (age 30–74 years) 4+ 1.33 (0.95, 1.86) HR Primary
Jacobs1999 CPS-II (age 75+ years) 1 1.07 (0.64, 1.78) HR Primary
Jacobs1999 CPS-II (age 75+ years) 2 to 3 0.72 (0.45, 1.16) HR Primary
Jacobs1999 CPS-II (age 75+ years) 4+ 1.03 (0.70, 1.51) HR Primary
Shanks1998 CPS-I None 1.01 (0.96, 1.07) IRR Primary
Shanks1998 CPS-I Slight 1.23 (1.07, 1.41) IRR Primary
Shanks1998 CPS-I Moderate-deep 1.37 (1.07, 1.75) IRR Primary
Shanks1998 CPS-I None 1.02 (0.92, 1.13) IRR Secondary
Shanks1998 CPS-I Slight 1.1 (0.93, 1.30) IRR Secondary
Shanks1998 CPS-I Moderate-deep 1.23 (0.99, 1.51) IRR Secondary
Jacobs1999 CPS-II (age 30–74 years) No inhalation 1.25 (0.96, 1.62) HR Primary
Jacobs1999 CPS-II (age 30–74 years) Inhalation 1.6 (1.06, 2.41) HR Primary
Jacobs1999 CPS-II (age 75+ years) No inhalation 0.87 (0.62, 1.22) HR Primary
Jacobs1999 CPS-II (age 75+ years) Inhalation 0.93 (0.49, 1.75) HR Primary
Jacobs1999 CPS-II (age 30–74 years) <25 1.03 (0.64, 1.65) HR Primary
Jacobs1999 CPS-II (age 30–74 years) 25+ 1.42 (1.11, 1.82) HR Primary
Jacobs1999 CPS-II (age 75+ years) <25 0.75 (0.28, 2.00) HR Primary
Jacobs1999 CPS-II (age 75+ years) 25+ 0.95 (0.70, 1.28) HR Primary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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was still highly elevated for oral, esophageal, and laryn-
geal cancer among primary cigar smokers reporting no
inhalation, particularly in CPS-I which is consistent with
the observation that cigar smoke is inhaled regardless of
self-reported inhalation [40]. It is also notable that ele-
vated risks of oral, esophageal, laryngeal cancers, and
aortic aneurysm were observed among primary cigar
smokers who smoked 1–2 cigars per day, although most
of these risks did not reach statistical significance due to
small sample size.
In CPS I, the risks were considerably higher for sec-
ondary cigar smokers than for primary cigar smokers for
lung cancer (MRs = 6.29 and 2.1, respectively) and
COPD (MRs = 4.39 and 1.42, respectively). As men-
tioned in the Introduction, the difference in risks could
be due to differences in inhalation patterns between sec-
ondary cigar smokers and primary cigar smokers. Also,
irreversible damage to the lungs due to past cigarette
use can also explain the higher risks of lung cancer and
COPD in secondary cigar smokers than in primary cigar
smokers. These differences in risks between primary and
secondary cigar smoking further reinforce the fact that
exclusion of past cigarette smoking would better isolate
the effects of cigar smoking for estimating disease risk.
Our results for mortality are consistent with recent stud-
ies of cigar smoking and incident cancers, such as those
from the European Prospective Investigation into Cancer
and Nutrition (EPIC) cohort and the International Head
and Neck Cancer Epidemiology (INHANCE) Consortium.
EPIC is a large multi-country cohort study of approxi-
mately half a million adults aged 35 to 70 years enrolled
between 1991 and 1998 with a median of 9 years of follow
up [41]. There were a total of 1,451 current (74%) or
former (26%) cigar smokers who had never smoked ciga-
rettes or pipes. Among the exclusive, current cigar
smokers significantly elevated risks of lung (HR = 3.9) and
upper aerodigestive tract (UADT) (oral cavity, larynx,
esophagus excluding esophageal adenocarcinoma) (HR =
Table 21 Current cigar smoking and stroke








Kahn1966 Dorn study 135 1.08 (0.91, 1.28) SMR Age ICD 7: 330-334
Shanks1998 CPS-I 431 0.96 (0.87, 1.06) IRR Primary Age
Shanks1998 CPS-I 133 0.92 (0.77, 1.09) IRR Secondary Age
Current Cigar and/or Pipe
Haheim1996 Oslo study 7 3.6 (1.05, 12.30) HR Age, blood pressure/
hypertension, fasting
glucose/diabetes
ICD 8, 9: 430-438
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; primary cigar and/or pipe smoking: current,
exclusive cigar and/or pipe smoking with no previous history of cigarette smoking; secondary cigar smoking: current, exclusive cigar smoking with previous
history of cigarette or pipe smoking; secondary cigar and/or pipe smoking: current, exclusive cigar and/or pipe smoking with previous history of
cigarette smoking.
Table 22 Current cigar smoking and stroke by inhalation level and cigars per day
Study Cohort name Inhalation level Cigars per day Effect estimate 95% CI Measure Primary/secondary*
Shanks1998 CPS-I 1 to 2 1.01 (0.88, 1.17) IRR Primary
Shanks1998 CPS-I 3 to 4 1.05 (0.88, 1.23) IRR Primary
Shanks1998 CPS-I 5+ 0.79 (0.64, 0.97) IRR Primary
Shanks1998 CPS-I 1 to 2 0.95 (0.71, 1.26) IRR Secondary
Shanks1998 CPS-I 3 to 4 0.92 (0.67, 1.24) IRR Secondary
Shanks1998 CPS-I 5+ 0.89 (0.64, 1.22) IRR Secondary
Shanks1998 CPS-I None 0.91 (0.82, 1.02) IRR Primary
Shanks1998 CPS-I Slight 1.06 (0.79, 1.39) IRR Primary
Shanks1998 CPS-I Moderate-deep 1.22 (0.74, 1.91) IRR Primary
Shanks1998 CPS-I None 0.95 (0.76, 1.18) IRR Secondary
Shanks1998 CPS-I Slight 0.83 (0.55, 1.20) IRR Secondary
Shanks1998 CPS-I Moderate-deep 0.88 (0.52, 1.38) IRR Secondary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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3.5) cancers as well as any tobacco-related cancer (HR =
1.6) were observed. The risk of combined lung/UADT/
bladder cancer and all tobacco-related cancer increased
with increasing inhalation level and increasing duration,
but significantly elevated risk of any tobacco-related can-
cer was still observed when no inhalation was reported.
Risk of lung/UADT/bladder cancer increased with increas-
ing cigars smoked per day and was significantly increased
across all cigar sizes (small, medium, and large). In a
pooled analysis of 19 studies as part of the INHANCE
Consortium (comprising 13,935 cases and 18,691 controls
from 1981 to 2007), the associations between tobacco
smoking (cigarette, cigar and pipe) and head and neck
cancers (cancers of the oral cavity, pharynx, and larynx)
were assessed [42]. Roughly one-third of the study partici-
pants were from the United States (35% of cases and 36%
of controls), and most of the remaining subjects were from
Latin America (28% of cases and 17% of controls) or Italy
(18% of cases and 29% of controls). Among never cigarette
smokers, the odds ratio (OR) for ever cigar smoking
and head and neck cancers was significantly elevated
(OR = 2.54, 95% CI = 1.93, 3.34), and increased with
increasing frequency and duration of cigar smoking
(p-trends ≤ 0.0001). At the same time, ORs for cigar
and head and neck cancer were not elevated among
ever cigarette smokers. In summary, the cigar associa-
tions from studies of incident disease are generally
consistent with those of cause-specific mortality.
Our systematic review is subject to certain limitations.
The studies included in this review were largely limited
to study populations of white men in North America
and Europe who smoked cigars in the 1960s or earlier.
The predominant cigar type studied was the large cigar,
whereas today, the US. cigar market consists of products
manufactured with various shapes, sizes, tips, filters and
packaging [3]. Limited data were available for a number
of smoking-related cancers, including stomach, colorec-
tal, and liver cancer. Finally, studies were often under-
powered for detecting associations at the lowest levels of
exposure.
Table 23 Current cigar smoking and aortic aneurysm









Kahn1966 Dorn study 24 2.06 (1.32, 3.07) SMR Age ICD 7: 450
Carstensen1987 Swedish Census Cohort 4 5.1 (1.33, 13.19) SMR Age, residence ICD 8: 451
Shanks1998 CPS-I 46 1.76 (1.29, 2.35) IRR Primary Age
Shanks1998 CPS-I 31 2.82 (1.91, 4.00) IRR Secondary Age
Current Cigar and/or Pipe
Strachan1991 Whitehall study 5.4 (1.90, 15.30) OR Age ICD 8: 441
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; primary cigar and/or pipe smoking: current,
exclusive cigar and/or pipe smoking with no previous history of cigarette smoking; secondary cigar smoking: current, exclusive cigar smoking with previous
history of cigarette or pipe smoking; secondary cigar and/or pipe smoking: current, exclusive cigar and/or pipe smoking with previous history of
cigarette smoking.
Table 24 Current cigar smoking and aortic aneurysm by inhalation level and cigars per day
Study Cohort name Inhalation level Cigars per day Effect estimate 95% CI Measure Primary/secondary*
Shanks1998 CPS-I 1 to 2 1.82 (1.11, 2.81) IRR Primary
Shanks1998 CPS-I 3 to 4 0.88 (0.35, 1.82) IRR Primary
Shanks1998 CPS-I 5+ 2.62 (1.58, 4.09) IRR Primary
Shanks1998 CPS-I 1 to 2 3.03 (1.51, 5.43) IRR Secondary
Shanks1998 CPS-I 3 to 4 2.8 (1.34, 5.16) IRR Secondary
Shanks1998 CPS-I 5+ 2.64 (1.26, 4.85) IRR Secondary
Shanks1998 CPS-I None 1.73 (1.22, 2.39) IRR Primary
Shanks1998 CPS-I Slight 1 (0.20, 2.92) IRR Primary
Shanks1998 CPS-I Moderate-deep 4.94 (1.59, 11.52) IRR Primary
Shanks1998 CPS-I None 2.18 (1.22, 3.59) IRR Secondary
Shanks1998 CPS-I Slight 3.52 (1.69, 6.47) IRR Secondary
Shanks1998 CPS-I Moderate-deep 2.94 (0.95, 6.87) IRR Secondary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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Given the changes in cigar use patterns in the US and
elsewhere since the 1960s, this review highlights the crit-
ical need for updated estimates of mortality risks due to
cigar smoking. Additional studies that include women,
non-whites, and younger adults in contemporary cohorts
from the 1990s or later would better reflect current
trends in cigar use. Studies that distinguish primary from
secondary cigar smokers and exclude other current to-
bacco smokers would better isolate the effects of cigar
smoking from other tobacco use. Data collection and
analysis that include detailed information on the types of
cigars typically used, the average number of cigars
smoked per day, the depth of inhalation of cigar smoke,
and the number of years smoking cigars would give a
better sense of any dose–response relationship. Future
studies incorporating biomarkers of tobacco exposure
and potential harm such as cotinine and NNAL would
better assess the levels of exposure to toxic constituents
Table 25 Current cigar smoking and chronic obstructive pulmonary disease (COPD)









Kahn1966 Dorn study 5 0.79 (0.25, 1.86) SMR Age ICD 7: 500–502,
527.1





Men 22 3.7 (1.10,
12.00)
HR Age ICD 8: 490-492
Lange1992 Copenhagen
City Heart Study
Women 10 10 (2.30,
48.00)
HR Age ICD 8: 490-492
Shanks1998 CPS-I 30 1.42 (0.96, 2.03) IRR Primary Age
Shanks1998 CPS-I 33 4.39 (3.02, 6.16) IRR Secondary Age
Current Cigar and/or Pipe
Wald1997 British United Provident
Association
40 1.11 (0.78, 1.59) HR Primary Age ICD 9: 416, 491–492,
496, 519
Wald1997 British United Provident
Association
35 1.68 (1.16, 2.45) HR Secondary Age ICD 9: 416, 491–492,
496, 519
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; primary cigar and/or pipe smoking: current,
exclusive cigar and/or pipe smoking with no previous history of cigarette smoking; secondary cigar smoking: current, exclusive cigar smoking with previous
history of cigarette or pipe smoking; secondary cigar and/or pipe smoking: current, exclusive cigar and/or pipe smoking with previous history of
cigarette smoking.
Table 26 Current cigar smoking and chronic obstructive pulmonary disease (COPD) by inhalation level and cigars per
day
Study Cohort name Inhalation level Cigars per day Effect estimate 95% CI Measure Primary/secondary*
Shanks1998 CPS-I 1 to 2 1.39 (0.74 2.38) IRR Primary
Shanks1998 CPS-I 3 to 4 1.78 (0.89 3.18) IRR Primary
Shanks1998 CPS-I 5+ 1.03 (0.37 2.23) IRR Primary
Shanks1998 CPS-I 1 to 2 2.64 (1.06 5.44) IRR Secondary
Shanks1998 CPS-I 3 to 4 4.33 (2.07 7.97) IRR Secondary
Shanks1998 CPS-I 5+ 6.68 (3.82 10.85) IRR Secondary
Shanks1998 CPS-I None 1.09 (0.66 1.70) IRR Primary
Shanks1998 CPS-I Slight 2.05 (0.66 4.77) IRR Primary
Shanks1998 CPS-I Moderate-deep 4.52 (0.91 13.22) IRR Primary
Shanks1998 CPS-I None 3.36 (1.96 5.39) IRR Secondary
Shanks1998 CPS-I Slight 7.68 (3.31 15.14) IRR Secondary
Shanks1998 CPS-I Moderate-deep 5.84 (2.34 12.02) IRR Secondary
*Primary cigar smoking: current, exclusive cigar smoking with no previous history of cigarette or pipe smoking; secondary cigar smoking: current, exclusive cigar
smoking with previous history of cigarette or pipe smoking.
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and intermediate health effects in cigar smokers, espe-
cially across cigar types and in comparison with cigarette
smokers.
Conclusions
In summary, cigar smoking carries many of the same
health risks as cigarette smoking, which is consistent
with the fact that the two products share similar levels
of many of the same harmful constituents. Mortality
risks from cigar smoking vary by level of exposure as
measured by cigars per day and inhalation level. We
have observed that some risks associated with cigar
smoking can be as high or higher than those associated
with cigarette smoking, especially at the highest doses
and levels of inhalation for cigar smoking. However,
even when no inhalation of cigar smoke is reported,
risks of death from cancers of the upper aerodigestive
tract (oral cavity, larynx, esophagus) are still highly ele-
vated. This body of research would be strengthened by
future studies that focus on primary cigar smoking, in-
corporate more contemporary and diverse study popula-
tions to better reflect the current patterns of cigar use in
the US. Ideally, these studies would also collect detailed
information on cigar type, level of exposure, and bio-
markers of exposure and potential harm.
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